{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T11:03:59Z","timestamp":1756811039266,"version":"3.32.0"},"reference-count":169,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.psychres.2024.115962","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T16:11:57Z","timestamp":1715875917000},"page":"115962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Implication of the endocannabidiome and metabolic pathways in fragile X syndrome pathophysiology"],"prefix":"10.1016","volume":"337","author":[{"given":"Olivier","family":"Dionne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armita","family":"Abolghasemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Corbin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artuela","family":"\u00c7aku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2024.115962_bib0001","doi-asserted-by":"crossref","first-page":"10815","DOI":"10.3390\/ijms231810815","article-title":"Alteration of Fatty Acid Profile in Fragile X Syndrome","volume":"23","author":"Abolghasemi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.psychres.2024.115962_bib0002","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1096\/fj.05-3995fje","article-title":"The endocannabinoid system drives neural progenitor proliferation","volume":"19","author":"Aguado","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.psychres.2024.115962_bib0003","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1523\/JNEUROSCI.3101-05.2006","article-title":"The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells","volume":"26","author":"Aguado","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psychres.2024.115962_bib0004","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.3390\/ijms21124448","article-title":"Cannabis, the Endocannabinoid System and Immunity\u2014The Journey from the Bedside to the Bench and Back","volume":"21","author":"Almogi-Hazan","year":"2020","journal-title":"Int. J. Mol. Sci."},{"year":"2013","series-title":"Diagnostic and Statistical Manual of Mental disorders: DSM-5","key":"10.1016\/j.psychres.2024.115962_bib0005"},{"key":"10.1016\/j.psychres.2024.115962_bib0006","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3389\/fncel.2019.00424","article-title":"The Endocannabinoid System as a Window Into Microglial Biology and Its Relationship to","volume":"13","author":"Araujo","year":"2019","journal-title":"Autism. Front Cell Neurosci"},{"key":"10.1016\/j.psychres.2024.115962_bib0007","doi-asserted-by":"crossref","first-page":"6496","DOI":"10.1073\/pnas.94.12.6496","article-title":"Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase","volume":"94","author":"Asada","year":"1997","journal-title":"Proc. Natl. Acad. Sci. u S. a"},{"key":"10.1016\/j.psychres.2024.115962_bib0008","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.phrs.2017.02.022","article-title":"The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors","volume":"119","author":"Bakas","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.psychres.2024.115962_bib0009","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3945\/jn.109.104844","article-title":"Endocannabinoids May Mediate the Ability of (n-3) Fatty Acids to Reduce Ectopic Fat and Inflammatory Mediators in Obese Zucker Rats","volume":"139","author":"Batetta","year":"2009","journal-title":"J. Nutr."},{"key":"10.1016\/j.psychres.2024.115962_bib0010","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.mpsur.2021.06.012","article-title":"An overview of the nervous system","volume":"39","author":"Bazira","year":"2021","journal-title":"Surgery (Oxford)"},{"key":"10.1016\/j.psychres.2024.115962_bib0011","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.tins.2004.04.009","article-title":"The mGluR theory of fragile X mental retardation","volume":"27","author":"Bear","year":"2004","journal-title":"Trends. Neurosci."},{"key":"10.1016\/j.psychres.2024.115962_bib0012","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/hmg\/ddn089","article-title":"Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations","volume":"17","author":"Benzinou","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.psychres.2024.115962_bib0013","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","article-title":"The Mechanisms of Action of PPARs","volume":"53","author":"Berger","year":"2002","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.psychres.2024.115962_bib0014","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s11689-022-09466-6","article-title":"A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)","volume":"14","author":"Berry-Kravis","year":"2022","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.psychres.2024.115962_bib0015","doi-asserted-by":"crossref","DOI":"10.1186\/s11689-016-9181-6","article-title":"Arbaclofen in fragile X syndrome: results of phase 3 trials","volume":"9","author":"Berry-Kravis","year":"2017","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.psychres.2024.115962_bib0016","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s11689-016-9181-6","article-title":"Arbaclofen in fragile X syndrome: results of phase 3 trials","volume":"9","author":"Berry-Kravis","year":"2017","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.psychres.2024.115962_bib0017","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/jmg.2008.063701","article-title":"A pilot open label, single dose trial of fenobam in adults with fragile X syndrome","volume":"46","author":"Berry-Kravis","year":"2009","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.psychres.2024.115962_bib0018","doi-asserted-by":"crossref","first-page":"152ra127","DOI":"10.1126\/scitranslmed.3004214","article-title":"Effects of STX209 (Arbaclofen) on Neurobehavioral Function in Children and Adults with Fragile X Syndrome: a Randomized, Controlled, Phase 2 Trial","volume":"4","author":"Berry-Kravis","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.psychres.2024.115962_bib0019","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1146\/annurev-neuro-060909-153138","article-title":"The Pathophysiology of Fragile X (and What It Teaches Us about Synapses)","volume":"35","author":"Bhakar","year":"2012","journal-title":"Annu Rev. Neurosci."},{"key":"10.1016\/j.psychres.2024.115962_bib0020","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.psychres.2024.115962_bib0021","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0301-0082(03)00002-9","article-title":"Roles of the mammalian subventricular zone in brain development","volume":"69","author":"Brazel","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.psychres.2024.115962_bib0022","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nm1775","article-title":"Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms","volume":"14","author":"Buettner","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.psychres.2024.115962_bib0023","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nm.3127","article-title":"Targeting the endocannabinoid system in the treatment of fragile X syndrome","volume":"19","author":"Busquets-Garcia","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.psychres.2024.115962_bib0024","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2012.09.020","article-title":"Endocannabinoid signaling and synaptic function","volume":"76","author":"Castillo","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.psychres.2024.115962_bib0025","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/oby.23368","article-title":"Height and BMI in fragile X syndrome: a longitudinal assessment","volume":"30","author":"Choo","year":"2022","journal-title":"Obesity"},{"key":"10.1016\/j.psychres.2024.115962_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2018.00420","article-title":"Involvement of TRPV1 Channels in Energy Homeostasis","volume":"9","author":"Christie","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.psychres.2024.115962_bib0027","doi-asserted-by":"crossref","DOI":"10.1186\/s13052-017-0355-y","article-title":"Fragile X syndrome: a review of clinical and molecular diagnoses","volume":"43","author":"Ciaccio","year":"2017","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.psychres.2024.115962_bib0028","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/nn.2632","article-title":"Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism","volume":"13","author":"Clapper","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.psychres.2024.115962_bib0029","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.3390\/ijms22042103","article-title":"The Endocannabinoid System and Invertebrate Neurodevelopment and Regeneration","volume":"22","author":"Clarke","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.psychres.2024.115962_bib0030","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199602013340503","article-title":"Serum immunoreactive-leptin concentrations in normal-weight and obese humans","volume":"334","author":"Considine","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psychres.2024.115962_bib0031","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neuron.2015.06.017","article-title":"Altered neuronal and circuit excitability in Fragile X Syndrome","volume":"87","author":"Contractor","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.psychres.2024.115962_bib0032","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1177\/0269881115587958","article-title":"Omega-3 polyunsaturated fatty acid supplementation and cognition: a systematic review and meta-analysis","volume":"29","author":"Cooper","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2024.115962_bib0033","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/hmg\/6.9.1465","article-title":"The fragile X mental retardation protein is associated with poly(A)+ mRNA in actively translating polyribosomes","volume":"6","author":"Corbin","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.psychres.2024.115962_bib0034","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.ijo.0800451","article-title":"Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults","volume":"21","author":"Couet","year":"1997","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.psychres.2024.115962_bib0035","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.coph.2004.05.007","article-title":"The gastrointestinal pharmacology of cannabinoids: an update","volume":"4","author":"Coutts","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.psychres.2024.115962_bib0036","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1038\/nn.3379","article-title":"The translation of translational control by FMRP: therapeutic targets for FXS","volume":"16","author":"Darnell","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.psychres.2024.115962_bib0037","first-page":"605","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.psychres.2024.115962_bib0038","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2008.11.075","article-title":"Expression of the GABAergic system in animal models for fragile X syndrome and fragile X associated tremor\/ataxia syndrome (FXTAS)","volume":"1253","author":"D'Hulst","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.psychres.2024.115962_bib0039","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrd.2018.115","article-title":"New approaches and challenges to targeting the endocannabinoid system","volume":"17","author":"Di Marzo","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.psychres.2024.115962_bib0040","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1007\/s00125-008-1048-2","article-title":"The endocannabinoid system in obesity and type 2 diabetes","volume":"51","author":"Di Marzo","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.psychres.2024.115962_bib0041","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrendo.2009.197","article-title":"CB1 antagonists for obesity\u2014What lessons have we learned from rimonabant?","volume":"5","author":"Di Marzo","year":"2009","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.psychres.2024.115962_bib0042","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/35071088","article-title":"Leptin-regulated endocannabinoids are involved in maintaining food intake","volume":"410","author":"Di Marzo","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.psychres.2024.115962_bib0043","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s13311-015-0374-6","article-title":"The Endocannabinoid System and its Modulation by Phytocannabinoids","volume":"12","author":"Di Marzo","year":"2015","journal-title":"Neurotherapeutics."},{"key":"10.1016\/j.psychres.2024.115962_bib0044","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1098\/rstb.2011.0385","article-title":"Endocannabinoids via CB1 receptors act as neurogenic niche cues during cortical development","volume":"367","author":"D\u00edaz-Alonso","year":"2012","journal-title":"Phil. Trans. R. Soc. B"},{"key":"10.1016\/j.psychres.2024.115962_bib0045","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1073\/pnas.152334899","article-title":"Brain monoglyceride lipase participating in endocannabinoid inactivation","volume":"99","author":"Dinh","year":"2002","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.psychres.2024.115962_bib0046","first-page":"433","article-title":"An \u201cOmic\u201d Overview of Fragile X Syndrome","volume":"10","author":"Dionne","year":"2021","journal-title":"Biology. (Basel)"},{"key":"10.1016\/j.psychres.2024.115962_bib0047","doi-asserted-by":"crossref","first-page":"15148","DOI":"10.1038\/s41598-021-94027-5","article-title":"A new strategy to uncover fragile X proteomic biomarkers using the nascent proteome of peripheral blood mononuclear cells (PBMCs)","volume":"11","author":"Dionne","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.psychres.2024.115962_bib0048","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251367","article-title":"Rates of protein synthesis are reduced in peripheral blood mononuclear cells (PBMCs) from fragile X individuals","volume":"16","author":"Dionne","year":"2021","journal-title":"PLoS. One"},{"key":"10.1016\/j.psychres.2024.115962_bib0049","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.neuron.2007.12.001","article-title":"Correction of Fragile X Syndrome in Mice","volume":"56","author":"D\u00f6len","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.psychres.2024.115962_bib0050","doi-asserted-by":"crossref","first-page":"e60771","DOI":"10.7554\/eLife.60771","article-title":"CB1R regulates soluble leptin receptor levels via CHOP, contributing to hepatic leptin resistance","volume":"9","author":"Drori","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.psychres.2024.115962_bib0051","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1515\/tnsci-2017-0002","article-title":"Fragile X Syndrome: lessons Learned from the Most Translated Neurodevelopmental Disorder in Clinical Trials","volume":"8","author":"Duy","year":"2017","journal-title":"Transl. Neurosci."},{"key":"10.1016\/j.psychres.2024.115962_bib0052","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.2337\/diabetes.54.10.2838","article-title":"Activation of the peripheral endocannabinoid system in human obesity","volume":"54","author":"Engeli","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.psychres.2024.115962_bib0053","first-page":"264","article-title":"Open-label riluzole in fragile X syndrome","volume":"1380","author":"Erickson","year":"2011","journal-title":"Brain Research, The Emerging Neuroscience of Autism Spectrum Disorders"},{"key":"10.1016\/j.psychres.2024.115962_bib0054","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00213-013-3022-z","article-title":"Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome","volume":"228","author":"Erickson","year":"2013","journal-title":"Psychopharmacology. (Berl)"},{"key":"10.1016\/j.psychres.2024.115962_bib0055","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1194\/jlr.E400004-JLR200","article-title":"A comprehensive classification system for lipids1","volume":"46","author":"Fahy","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.psychres.2024.115962_bib0056","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/MED.0000000000000184","article-title":"Leptin applications in 2015: what have we learned about leptin and obesity?","volume":"22","author":"Farr","year":"2015","journal-title":"Curr. Opin. Endocrinol. Diabetes. Obes."},{"key":"10.1016\/j.psychres.2024.115962_bib0057","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.bbamem.2017.05.003","article-title":"The role of Omega-3 and Omega-9 fatty acids for the treatment of neuropathic pain after neurotrauma","volume":"1859","author":"Gal\u00e1n-Arriero","year":"2017","journal-title":"Biochimica et Biophysica Acta (BBA) - Biomembranes"},{"key":"10.1016\/j.psychres.2024.115962_bib0058","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nm.4335","article-title":"Metformin ameliorates core deficits in a mouse model of fragile X syndrome","volume":"23","author":"Gantois","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.psychres.2024.115962_bib0059","first-page":"99","article-title":"Epigenetic regulation in neurodevelopment and neurodegenerative diseases","volume":"264","author":"Gapp","year":"2014","journal-title":"Neuroscience, Epigenetics in Brain Function"},{"key":"10.1016\/j.psychres.2024.115962_bib0060","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/s41593-018-0231-0","article-title":"Impaired perceptual learning in a mouse model of Fragile X syndrome is mediated by parvalbumin neuron dysfunction and is reversible","volume":"21","author":"Goel","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.psychres.2024.115962_bib0061","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/glia.21061","article-title":"The constitutive production of the endocannabinoid 2-arachidonoylglycerol participates in oligodendrocyte differentiation","volume":"58","author":"Gomez","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.psychres.2024.115962_bib0062","doi-asserted-by":"crossref","first-page":"9612","DOI":"10.1523\/JNEUROSCI.22-21-09612.2002","article-title":"A Peripheral Mechanism for CB1 Cannabinoid Receptor-Dependent Modulation of Feeding","volume":"22","author":"G\u00f3mez","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psychres.2024.115962_bib0063","doi-asserted-by":"crossref","DOI":"10.3390\/genes7090056","article-title":"Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model","volume":"7","author":"Gomis-Gonz\u00e1lez","year":"2016","journal-title":"Genes. (Basel)"},{"key":"10.1016\/j.psychres.2024.115962_bib0064","first-page":"709","article-title":"Fragile X mental retardation 1 gene enhances the translation of large autism-related proteins","volume":"361","author":"Greenblatt","year":"2018","journal-title":"Science (1979)"},{"key":"10.1016\/j.psychres.2024.115962_bib0065","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34978-4","article-title":"Mavoglurant in Fragile X Syndrome: results of two open-label, extension trials in adults and adolescents","volume":"8","author":"Hagerman","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.psychres.2024.115962_bib0066","doi-asserted-by":"crossref","first-page":"17065","DOI":"10.1038\/nrdp.2017.65","article-title":"Fragile X syndrome","volume":"3","author":"Hagerman","year":"2017","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.psychres.2024.115962_bib0067","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nm0995-953","article-title":"Increased obese mRNA expression in omental fat cells from massively obese humans","volume":"1","author":"Hamilton","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.psychres.2024.115962_bib0068","series-title":"The Endocannabinoidome","first-page":"1","article-title":"Chapter 1 - Non-endocannabinoid N-Acylethanolamines and Monoacylglycerols: old Molecules New Targets","author":"Hansen","year":"2015"},{"key":"10.1016\/j.psychres.2024.115962_bib0069","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.tips.2006.12.004","article-title":"The emerging functions of endocannabinoid signaling during CNS development","volume":"28","author":"Harkany","year":"2007","journal-title":"Trends. Pharmacol. Sci."},{"key":"10.1016\/j.psychres.2024.115962_bib0070","doi-asserted-by":"crossref","DOI":"10.1186\/s11689-019-9277-x","article-title":"A phase 1\/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome","volume":"11","author":"Heussler","year":"2019","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.psychres.2024.115962_bib0071","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nrn2810","article-title":"Epigenetic control of neural precursor cell fate during development","volume":"11","author":"Hirabayashi","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.psychres.2024.115962_bib0072","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International Union of Pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.psychres.2024.115962_bib0073","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115392","article-title":"Transient receptor potential ankyrin 1 (TRPA1) modulators: recent update and future perspective","volume":"257","author":"Hu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.psychres.2024.115962_bib0074","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.neubiorev.2021.10.009","article-title":"ERK\/MAPK signalling in the developing brain: perturbations and consequences","volume":"131","author":"Iroegbu","year":"2021","journal-title":"Neuroscience & Biobehavioral Reviews"},{"key":"10.1016\/j.psychres.2024.115962_bib0075","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3390\/nu11112704","article-title":"Leptin, Obesity, and Leptin Resistance: where Are We 25 Years Later?","volume":"11","author":"Izquierdo","year":"2019","journal-title":"Nutrients."},{"key":"10.1016\/j.psychres.2024.115962_bib0076","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pharmthera.2009.12.005","article-title":"Cannabinoids and the gut: new developments and emerging concepts","volume":"126","author":"Izzo","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.psychres.2024.115962_bib0077","doi-asserted-by":"crossref","first-page":"64ra1","DOI":"10.1126\/scitranslmed.3001708","article-title":"Epigenetic Modification of the FMR1 Gene in Fragile X Syndrome Is Associated with Differential Response to the mGluR5 Antagonist AFQ056","volume":"3","author":"Jacquemont","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.psychres.2024.115962_bib0078","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.neuron.2005.10.021","article-title":"Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit","volume":"48","author":"Jo","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.psychres.2024.115962_bib0079","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.nut.2015.10.019","article-title":"Abnormal fatty acids in Canadian children with autism","volume":"32","author":"Jory","year":"2016","journal-title":"Nutrition"},{"key":"10.1016\/j.psychres.2024.115962_bib0080","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/ncomms2045","article-title":"Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome","volume":"3","author":"Jung","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.psychres.2024.115962_bib0081","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00019.2008","article-title":"Endocannabinoid-Mediated Control of Synaptic Transmission","volume":"89","author":"Kano","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.psychres.2024.115962_bib0082","doi-asserted-by":"crossref","first-page":"27218","DOI":"10.1074\/jbc.272.43.27218","article-title":"cDNA Cloning, Tissue Distribution, and Identification of the Catalytic Triad of Monoglyceride Lipase: EVOLUTIONARY RELATIONSHIP TO ESTERASES, LYSOPHOSPHOLIPASES, AND HALOPEROXIDASES*","volume":"272","author":"Karlsson","year":"1997","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.psychres.2024.115962_bib0083","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.cell.2008.10.017","article-title":"The Autistic Neuron: troubled Translation?","volume":"135","author":"Kelleher","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.psychres.2024.115962_bib0084","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41583-018-0091-3","article-title":"Mitochondria as central regulators of neural stem cell fate and cognitive function","volume":"20","author":"Khacho","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.psychres.2024.115962_bib0085","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/sj.bjp.0704767","article-title":"Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol","volume":"136","author":"Kirkham","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.psychres.2024.115962_bib0086","series-title":"Mammalian Transient Receptor Potential (TRP) Cation Channels: Volume I, Handbook of Experimental Pharmacology","first-page":"247","article-title":"TRPV2","author":"Kojima","year":"2014"},{"key":"10.1016\/j.psychres.2024.115962_bib0087","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.643442","article-title":"Cannabidiol and Neurodevelopmental Disorders in Children","volume":"12","author":"Kwan Cheung","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.psychres.2024.115962_bib0088","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105881","article-title":"Multimodal assessment of the GABA system in patients with fragile-X syndrome and neurofibromatosis of type 1","volume":"174","author":"Lacroix","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.psychres.2024.115962_bib0089","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3390\/ijms21030747","article-title":"The Endocannabinoid System: a Target for Cancer Treatment","volume":"21","author":"Laezza","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.psychres.2024.115962_bib0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.glohj.2020.01.004","article-title":"Omega-3 fatty acids and mental health","volume":"4","author":"Lange","year":"2020","journal-title":"Global Health Journal"},{"key":"10.1016\/j.psychres.2024.115962_bib0091","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.psychres.2024.115962_bib0092","doi-asserted-by":"crossref","first-page":"24845","DOI":"10.1074\/jbc.M114.557025","article-title":"Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons","volume":"289","author":"Laprairie","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.psychres.2024.115962_bib0093","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/nu8010006","article-title":"DHA Effects in Brain Development and Function","volume":"8","author":"Lauritzen","year":"2016","journal-title":"Nutrients."},{"key":"10.1016\/j.psychres.2024.115962_bib0094","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.molmet.2019.01.002","article-title":"The translational regulator FMRP controls lipid and glucose metabolism in mice and humans","volume":"21","author":"Leboucher","year":"2019","journal-title":"Mol. Metab."},{"key":"10.1016\/j.psychres.2024.115962_bib0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1748-1716.2010.02216.x","article-title":"Cross-talk between adipose tissue and vasculature: role of adiponectin","volume":"203","author":"Li","year":"2011","journal-title":"Acta Physiologica"},{"key":"10.1016\/j.psychres.2024.115962_bib0096","doi-asserted-by":"crossref","first-page":"e43023","DOI":"10.1371\/journal.pone.0043023","article-title":"Design and Synthesis of Potent N-Acylethanolamine-hydrolyzing Acid Amidase (NAAA) Inhibitor as Anti-Inflammatory Compounds","volume":"7","author":"Li","year":"2012","journal-title":"PLoS. One"},{"key":"10.1016\/j.psychres.2024.115962_bib0097","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s11689-017-9207-8","article-title":"A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome","volume":"9","author":"Ligsay","year":"2017","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.psychres.2024.115962_bib0098","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000452336","article-title":"Plasma Levels of Leptin and Adiponectin in Fragile X Syndrome","volume":"23","author":"Lisik","year":"2016","journal-title":"Neuroimmunomodulation."},{"key":"10.1016\/j.psychres.2024.115962_bib0099","doi-asserted-by":"crossref","first-page":"13345","DOI":"10.1073\/pnas.0601832103","article-title":"A biosynthetic pathway for anandamide","volume":"103","author":"Liu","year":"2006","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.psychres.2024.115962_bib0100","first-page":"607","article-title":"Review of the Endocannabinoid System","volume":"6","author":"Lu","year":"2021","journal-title":"Biological Psychiatry: Cognitive Neuroscience and Neuroimaging"},{"key":"10.1016\/j.psychres.2024.115962_bib0101","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2017.00166","article-title":"Metabolism of the Endocannabinoid Anandamide: open Questions after 25 Years","volume":"10","author":"Maccarrone","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.psychres.2024.115962_bib0102","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.tips.2015.02.008","article-title":"Endocannabinoid signaling at the periphery: 50 years after THC","volume":"36","author":"Maccarrone","year":"2015","journal-title":"Trends. Pharmacol. Sci."},{"key":"10.1016\/j.psychres.2024.115962_bib0103","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/npp.2010.19","article-title":"Abnormal mGlu 5 Receptor\/Endocannabinoid Coupling in Mice Lacking FMRP and BC1 RNA","volume":"35","author":"Maccarrone","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2024.115962_bib0104","doi-asserted-by":"crossref","first-page":"9034","DOI":"10.1073\/pnas.92.20.9034","article-title":"Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes","volume":"92","author":"MacDougald","year":"1995","journal-title":"Proc. Natl. Acad. Sci. u S. a"},{"key":"10.1016\/j.psychres.2024.115962_bib0105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/3-540-26573-2_10","article-title":"Distribution of cannabinoid receptors in the central and peripheral nervous system","author":"Mackie","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.psychres.2024.115962_bib0106","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1210\/jc.2005-2679","article-title":"Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia","volume":"91","author":"Matias","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.psychres.2024.115962_bib0107","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.mce.2008.01.026","article-title":"Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: effect of high fat diets","volume":"286","author":"Matias","year":"2008","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.psychres.2024.115962_bib0108","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bph.12944","article-title":"Are cannabidiol and \u03949-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review","volume":"172","author":"McPartland","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.psychres.2024.115962_bib0109","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bph.12944","article-title":"Are cannabidiol and \u03949-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review","volume":"172","author":"McPartland","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.psychres.2024.115962_bib0110","first-page":"24","article-title":"The Important Role of the Endocannabinoid System and the Endocannabinoidome in Gut Health","volume":"25","author":"Meletis","year":"2019","journal-title":"Altern. Ther. Health Med."},{"key":"10.1016\/j.psychres.2024.115962_bib0111","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1017\/S0007114509382173","article-title":"Plasma n-3 Polyunsaturated Fatty Acids are negatively associated with obesity","volume":"102","author":"Micallef","year":"2009","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.psychres.2024.115962_bib0112","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jnim.2016.04.001","article-title":"Sex-dependent association between omega-3 index and body weight status in older Australians","volume":"5","author":"Mingay","year":"2016","journal-title":"J. Nutr. Intermed. Metab."},{"key":"10.1016\/j.psychres.2024.115962_bib0113","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/sj.npp.1300695","article-title":"Blood Levels of the Endocannabinoid Anandamide are Increased in Anorexia Nervosa and in Binge-Eating Disorder, but not in Bulimia Nervosa","volume":"30","author":"Monteleone","year":"2005","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.psychres.2024.115962_bib0114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-019-0650-z","article-title":"Hyperexcitability and impaired intracortical inhibition in patients with fragile-X syndrome","volume":"9","author":"Morin-Parent","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.psychres.2024.115962_bib0115","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12993-014-0048-2","article-title":"Reduced levels of plasma polyunsaturated fatty acids and serum carnitine in autistic children: relation to gastrointestinal manifestations","volume":"11","author":"Mostafa","year":"2015","journal-title":"Behavioral and Brain Functions"},{"key":"10.1016\/j.psychres.2024.115962_bib0116","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fnmol.2018.00487","article-title":"Cannabinoid Ligands Targeting TRP Channels","volume":"11","author":"Muller","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.psychres.2024.115962_bib0117","doi-asserted-by":"crossref","first-page":"255","DOI":"10.5582\/irdr.2016.01082","article-title":"The neurobiology of the Prader-Willi phenotype of fragile X syndrome","volume":"5","author":"Muzar","year":"2016","journal-title":"Intractable Rare Dis. Res."},{"key":"10.1016\/j.psychres.2024.115962_bib0118","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cmet.2012.01.002","article-title":"Challenges and opportunities of defining clinical leptin resistance","volume":"15","author":"Myers","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.psychres.2024.115962_bib0119","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/01.DBP.0000267563.18952.c9","article-title":"The Prader-Willi Phenotype of Fragile X Syndrome","volume":"28","author":"Nowicki","year":"2007","journal-title":"Journal of Developmental & Behavioral Pediatrics"},{"key":"10.1016\/j.psychres.2024.115962_bib0120","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.585887","article-title":"Leptin and Obesity: role and Clinical Implication","volume":"12","author":"Obradovic","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.psychres.2024.115962_bib0121","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/ejcn.2015.28","article-title":"Omega-3 fatty acids in the management of autism spectrum disorders: findings from an open-label pilot study in Singapore","volume":"69","author":"Ooi","year":"2015","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.psychres.2024.115962_bib0122","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2019.109666","article-title":"Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia","volume":"95","author":"Osborne","year":"2019","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2024.115962_bib0123","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI200523057","article-title":"Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity","volume":"115","author":"Osei-Hyiaman","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.psychres.2024.115962_bib0124","doi-asserted-by":"crossref","first-page":"15616","DOI":"10.1523\/JNEUROSCI.3888-10.2010","article-title":"Hypersensitivity to mGluR5 and ERK1\/2 Leads to Excessive Protein Synthesis in the Hippocampus of a Mouse Model of Fragile X Syndrome","volume":"30","author":"Osterweil","year":"2010","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.psychres.2024.115962_bib0125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/0269881111408457","article-title":"Endocannabinoids and the cardiovascular response to stress","volume":"26","author":"O'Sullivan","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2024.115962_bib0126","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2006.02.004","article-title":"Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents","volume":"3","author":"Overton","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.psychres.2024.115962_bib0127","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci9030059","article-title":"Modelling Protein Synthesis as A Biomarker in Fragile X Syndrome Patient-Derived Cells","volume":"9","author":"Pal","year":"2019","journal-title":"Brain Sci."},{"key":"10.1016\/j.psychres.2024.115962_bib0128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s11689-023-09475-z","article-title":"Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment","volume":"15","author":"Palumbo","year":"2023","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.psychres.2024.115962_bib0129","doi-asserted-by":"crossref","DOI":"10.1242\/dev.192161","article-title":"Endocannabinoid signalling in stem cells and cerebral organoids drives differentiation to deep layer projection neurons via CB1 receptors","volume":"147","author":"Para\u00edso-Luna","year":"2020","journal-title":"Development"},{"key":"10.1016\/j.psychres.2024.115962_bib0130","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.tins.2020.05.004","article-title":"Neurodevelopmental Disorders: from Genetics to Functional Pathways","volume":"43","author":"Parenti","year":"2020","journal-title":"Trends. Neurosci."},{"key":"10.1016\/j.psychres.2024.115962_bib0131","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156432","article-title":"Omega-3 and Omega-6 Polyunsaturated Fatty Acid Levels and Correlations with Symptoms in Children with Attention Deficit Hyperactivity Disorder, Autistic Spectrum Disorder and Typically Developing Controls","volume":"11","author":"Parletta","year":"2016","journal-title":"PLoS. One"},{"key":"10.1016\/j.psychres.2024.115962_bib0132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/endrev\/bnaa027","article-title":"Tissue-Specific Effects of Leptin on Glucose and Lipid Metabolism","volume":"42","author":"Pereira","year":"2020","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.psychres.2024.115962_bib0133","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(91)90125-I","article-title":"Absence of expression of the FMR-1 gene in fragile X syndrome","volume":"66","author":"Pieretti","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.psychres.2024.115962_bib0134","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s11689-021-09394-x","article-title":"Increased 2-arachidonoyl-sn-glycerol levels normalize cortical responses to sound and improve behaviors in Fmr1 KO mice","volume":"13","author":"Pirbhoy","year":"2021","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.psychres.2024.115962_bib0135","series-title":"The Endocannabinoidome","first-page":"137","article-title":"Chapter 9 - Endocannabinoidomics: \u201cOmics\u201d Approaches Applied to Endocannabinoids and Endocannabinoid-Like Mediators","author":"Piscitelli","year":"2015"},{"key":"10.1016\/j.psychres.2024.115962_bib0136","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/bdrb.20348","article-title":"Cannabinoid receptor 1 signaling in embryo neurodevelopment","volume":"95","author":"Psychoyos","year":"2012","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.psychres.2024.115962_bib0137","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bbr.2015.05.003","article-title":"Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome","volume":"291","author":"Qin","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.psychres.2024.115962_bib0138","doi-asserted-by":"crossref","first-page":"12125","DOI":"10.1523\/JNEUROSCI.3400-08.2008","article-title":"Crucial Role of CB2 Cannabinoid Receptor in the Regulation of Central Immune Responses during Neuropathic Pain","volume":"28","author":"Racz","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psychres.2024.115962_bib0139","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00430","article-title":"Modulation of the Endocannabinoid System as a Potential Anticancer Strategy","volume":"10","author":"Ramer","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.psychres.2024.115962_bib0140","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1352\/1944-7558-115.6.482","article-title":"Obesity, food selectivity, and physical activity in individuals with fragile X syndrome","volume":"115","author":"Raspa","year":"2010","journal-title":"Am. J. Intellect. Dev. Disabil."},{"key":"10.1016\/j.psychres.2024.115962_bib0141","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.3390\/molecules24071350","article-title":"Cannabinoid Actions on Neural Stem Cells: implications for Pathophysiology","volume":"24","author":"Rodrigues","year":"2019","journal-title":"Molecules."},{"key":"10.1016\/j.psychres.2024.115962_bib0142","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nrm2066","article-title":"Adipocyte differentiation from the inside out","volume":"7","author":"Rosen","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.psychres.2024.115962_bib0143","series-title":"TRP Ion Channel Function in Sensory Transduction and Cellular Signaling Cascades, Frontiers in Neuroscience","article-title":"TRPV1C Receptors and Signal Transduction","author":"Rosenbaum","year":"2007"},{"key":"10.1016\/j.psychres.2024.115962_bib0144","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/nu13020373","article-title":"What Role Does the Endocannabinoid System Play in the Pathogenesis of Obesity?","volume":"13","author":"Schulz","year":"2021","journal-title":"Nutrients."},{"key":"10.1016\/j.psychres.2024.115962_bib0145","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cmet.2013.03.001","article-title":"The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders","volume":"17","author":"Silvestri","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.psychres.2024.115962_bib0146","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/42015","article-title":"A second endogenous cannabinoid that modulates long-term potentiation","volume":"388","author":"Stella","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.psychres.2024.115962_bib0147","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2013.04.002","article-title":"Fmr1 deletion enhances and ultimately desensitizes CB(1) signaling in autaptic hippocampal neurons","volume":"56","author":"Straiker","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.psychres.2024.115962_bib0148","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1042\/bj20040031","article-title":"Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D","volume":"380","author":"SUN","year":"2004","journal-title":"Biochemical Journal"},{"key":"10.1016\/j.psychres.2024.115962_bib0149","doi-asserted-by":"crossref","first-page":"E1469","DOI":"10.1152\/ajpendo.00269.2012","article-title":"Regulation of GPR119 receptor activity with endocannabinoid-like lipids","volume":"303","author":"Syed","year":"2012","journal-title":"American Journal of Physiology-Endocrinology and Metabolism"},{"key":"10.1016\/j.psychres.2024.115962_bib0150","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.molmet.2017.06.010","article-title":"Peripheral cannabinoid-1 receptor blockade restores hypothalamic leptin signaling","volume":"6","author":"Tam","year":"2017","journal-title":"Mol. Metab."},{"key":"10.1016\/j.psychres.2024.115962_bib0151","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1523\/JNEUROSCI.4499-14.2015","article-title":"Homer protein-metabotropic glutamate receptor binding regulates endocannabinoid signaling and affects hyperexcitability in a mouse model of fragile X syndrome","volume":"35","author":"Tang","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psychres.2024.115962_bib0152","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S2215-0366(16)30376-5","article-title":"Neurodevelopmental disorders","volume":"4","author":"Thapar","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psychres.2024.115962_bib0153","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2018.00010","article-title":"Neuronal Lipid Metabolism: multiple Pathways Driving Functional Outcomes in Health and Disease","volume":"11","author":"Tracey","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.psychres.2024.115962_bib0154","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1471-244X-8-S1-S5","article-title":"Fatty acids and oxidative stress in psychiatric disorders","volume":"8","author":"Tsaluchidu","year":"2008","journal-title":"BMC. Psychiatry"},{"key":"10.1016\/j.psychres.2024.115962_bib0155","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5507\/bp.2011.038","article-title":"Fatty acids as biocompounds: their role in human metabolism, health and disease\u2013a review. Part 1: classification, dietary sources and biological functions","volume":"155","author":"Tvrzicka","year":"2011","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc. Czech. Repub."},{"key":"10.1016\/j.psychres.2024.115962_bib0156","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/2231-4040.90879","article-title":"The peroxisome proliferator-activated receptor: a family of nuclear receptors role in various diseases","volume":"2","author":"Tyagi","year":"2011","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.psychres.2024.115962_bib0157","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/biof.131","article-title":"Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol","volume":"37","author":"Ueda","year":"2011","journal-title":"Biofactors"},{"key":"10.1016\/j.psychres.2024.115962_bib0158","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1054\/plef.2001.0281","article-title":"Plasma fatty acid levels in autistic children","volume":"65","author":"Vancassel","year":"2001","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA)"},{"key":"10.1016\/j.psychres.2024.115962_bib0159","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0092-8674(91)90397-H","article-title":"Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome","volume":"65","author":"Verkerk","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.psychres.2024.115962_bib0160","doi-asserted-by":"crossref","first-page":"E2695","DOI":"10.1073\/pnas.1524589113","article-title":"\u03b1\/\u03b2-Hydrolase domain-containing 6 (ABHD6) negatively regulates the surface delivery and synaptic function of AMPA receptors","volume":"113","author":"Wei","year":"2016","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.psychres.2024.115962_bib0161","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s10803-014-2246-z","article-title":"DSM-5 Changes and the Prevalence of Parent-Reported Autism Spectrum Symptoms in Fragile X Syndrome","volume":"45","author":"Wheeler","year":"2015","journal-title":"J. Autism. Dev. Disord."},{"key":"10.1016\/j.psychres.2024.115962_bib0162","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049485","article-title":"Mouse models of fragile X-related disorders","volume":"16","author":"Willemsen","year":"2023","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.psychres.2024.115962_bib0163","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1677\/joe.0.1750735","article-title":"Leptin controls the fate of fatty acids in isolated rat white adipocytes","volume":"175","author":"Wn","year":"2002","journal-title":"Journal of Endocrinology"},{"key":"10.1016\/j.psychres.2024.115962_bib0164","doi-asserted-by":"crossref","first-page":"13603","DOI":"10.1523\/JNEUROSCI.2244-09.2009","article-title":"Molecular Reconstruction of mGluR5a-Mediated Endocannabinoid Signaling Cascade in Single Rat Sympathetic Neurons","volume":"29","author":"Won","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psychres.2024.115962_bib0165","doi-asserted-by":"crossref","first-page":"e856","DOI":"10.7717\/peerj.856","article-title":"Obesity genetics in mouse and human: back and forth, and back again","volume":"3","author":"Yazdi","year":"2015","journal-title":"PeerJ."},{"key":"10.1016\/j.psychres.2024.115962_bib0166","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/(SICI)1097-4547(19990615)56:6<565::AID-JNR2>3.0.CO;2-H","article-title":"Essential fatty acids are mediators of brain biochemistry and cognitive functions","volume":"56","author":"Yehuda","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.psychres.2024.115962_bib0167","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/npp.2017.177","article-title":"Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results","volume":"43","author":"Youssef","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2024.115962_bib0168","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.physbeh.2006.05.038","article-title":"The role of leptin in leptin resistance and obesity","volume":"88","author":"Zhang","year":"2006","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.psychres.2024.115962_bib0169","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid Receptors and the Endocannabinoid System: signaling and Function in the Central Nervous System","volume":"19","author":"Zou","year":"2018","journal-title":"Int. J. Mol. Sci."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178124002476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178124002476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T22:56:43Z","timestamp":1736204203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178124002476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":169,"alternative-id":["S0165178124002476"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2024.115962","relation":{},"ISSN":["0165-1781"],"issn-type":[{"type":"print","value":"0165-1781"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implication of the endocannabidiome and metabolic pathways in fragile X syndrome pathophysiology","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2024.115962","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115962"}}